Jim DiCesare, Sr. Director, Study Operations, IQVIA Clinical Trial Payments
Escalating competition for clinical trial sites, in tandem with other industry-wide challenges such as changing regulations; a lack of bandwidth and resources; identifying ideal sites…
Continue Reading
QuantHealth co-founders Arnon Horev and Orr (Ruti Benziman)
What You Should Know:
– In a decisive move towards faster and more efficient drug development, QuantHealth, a leading AI-powered clinical trial design company, has secured a strategic…
Continue Reading
BJC HealthCare and Saint Luke’s Health System have merged, forming a $10 billion integrated health system. This collaboration joins 24 hospitals and 44,000 employees under the BJC Health System umbrella. The merger aims to…
Continue Reading
ConcertAI will Invest in CancerLinQ to Provide its Members with Upgraded Quality Reporting, Industry-Leading Real-World Data, and AI-Powered Solutions for Accelerated Clinical Trials in a Multi-Year Cooperation Agreement with ASCO
ConcertAI today announced the acquisition…
Gary Shorter – Head, AI and Data Science, IQVIA Technologies
In the healthcare ecosystem, automation and data intelligence continue to gain momentum as artificial intelligence (AI) and machine learning (ML) are integrated to streamline and accelerate processes.
The clinical trial space is one area where…
Continue Reading
Two healthcare data companies joined forces on Thursday to address historical diversity and inclusion challenges in clinical trials. Atropos Health, a Palo Alto-based company that delivers clinical data to physicians at the point of…
Continue Reading
During the global pandemic, the world saw firsthand how essential clinical trials were in developing medicines to improve health and extend human life. Clinical research sites, including academic medical centers (AMC), non-AMCs and professional…
Continue Reading
What You Should Know: Yseop, a world-leading Generative AI company for life sciences, today announces the closing of a strategic investment round, with new investor Novartis (dRx Capital), joining existing investors Eli Lilly, NextStage…
Continue Reading
In this special two part series of Talking HealthTech, we focus on healthcare research and systemic change in these two discussions with Jade Barclay and Dale Trevor, who offer diverse perspectives on patient advocacy,…
Continue Reading
AI-aided colonoscopy shows promise in bolstering colorectal neoplasia detection, as per a recent meta-analysis. Evaluated against standard procedures, AI integration significantly reduces adenoma miss rates (AMRs) and enhances adenoma detection rates (ADRs). Findings reveal…
Continue Reading
